Early Alzheimer-type lesions in cognitively normal subjects

Neurobiol Aging. 2018 Feb:62:34-44. doi: 10.1016/j.neurobiolaging.2017.10.002. Epub 2017 Oct 13.

Abstract

Amyloid deposits and tau-immunoreactive neurofibrillary tangles, together with neuronal and synaptic loss, are the neuropathological hallmarks of Alzheimer's disease (AD). Both proteins are present in the normal brain during aging. However, the temporal sequence of their involvement in the onset of AD pathology remains controversial. To define whether amyloid β protein deposits or tau protein lesions appear first during normal brain aging, we performed an immunohistological study on serial sections from 105 autopsy brains (age range: 40-104 years) from patients free of clinical signs of cognitive decline, using anti-tau (AT8) and anti-amyloid (4G8) antibodies in the hippocampus, entorhinal cortex, inferior temporal cortex (Brodmann area 20), prefrontal cortex (Brodmann area 9), occipital cortex (Brodmann areas 17 and 18), and in the brainstem. All cases older than 48 years displayed at least a few neurofibrillary tangles, which appeared more frequently in the entorhinal than in the transentorhinal cortex. Tau pathology in these areas preceded tau inclusions in the brainstem. Furthermore, the first site of the apparition of tau pathology is inconsistent, being the entorhinal cortex in most cases, and in fewer cases, the transentorhinal region. There was no case presenting with amyloid deposition in the absence of neurofibrillary tangles, lending evidence to the fact that neurofibrillary tangles appear earlier than amyloid plaques during normal brain aging. However, the role of amyloid in promoting tau deposition cannot be excluded in some cases but may not represent the sole mechanism of disease induction and progression.

Keywords: Alzheimer's disease; Amyloid; Brain aging; Neurofibrillary tangle; Primary age-related tauopathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / metabolism*
  • Brain / metabolism*
  • Brain / pathology*
  • Cognition / physiology*
  • Cohort Studies
  • Female
  • Healthy Aging / metabolism*
  • Healthy Aging / pathology*
  • Humans
  • Male
  • Middle Aged
  • Nerve Degeneration*
  • Neurofibrillary Tangles / metabolism*
  • Neurofibrillary Tangles / pathology*
  • Tauopathies / metabolism
  • Tauopathies / pathology
  • tau Proteins / metabolism*

Substances

  • Amyloid beta-Peptides
  • tau Proteins